Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
K36 Therapeutics, Inc.
Eli Lilly and Company
Pfizer
Alterome Therapeutics, Inc.
Eli Lilly and Company
Orca Biosystems, Inc.
Boston Scientific Corporation
Stemline Therapeutics, Inc.
Pfizer
DL Analytics
Pathos AI, Inc.
Corcept Therapeutics
Genelux Corporation
Plus Therapeutics
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Cogent Biosciences, Inc.
Novartis
Endocyte
UroGen Pharma Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.
OncoSil Medical Limited
Concure Oncology-Breast Microseed Inc.